Table 2.
Clinical features of the 10 pSS patients with lung cancer
| No. | Gender | Age (year) | Smoking History | pSS lung involvement | Surrounding type | Pathological classification | Staging | Treatment |
|---|---|---|---|---|---|---|---|---|
| 1 | M | 48 | Y | Y | Y | Adenocarcinoma | UK | Withdrew |
| 2 | F | 63 | N | N | Y | Adenocarcinoma | Ib | Surgical +chemotherapy |
| 3 | F | 76 | N | N | N | SCLC | IV | Chemotherapy |
| 4 | F | 52 | N | Y | N | Adenocarcinoma | Ib | Surgical +chemotherapy |
| 5 | F | 55 | N | N | Y | Adenocarcinoma | Ib | Surgical |
| 6 | F | 72 | N | N | Y | Adenocarcinoma | IV | Targeted therapy |
| 7 | F | 56 | N | Y | Y | Adenocarcinoma | Ib | Surgical +chemotherapy |
| 8 | M | 62 | Y | Y | N | Adenocarcinoma | IIIb | Withdrew |
| 9 | F | 57 | N | N | N | Adenocarcinoma | IV | Chemotherapy |
| 10 | F | 67 | N | Y | N | Adenocarcinoma | IV | Targeted therapy |
Primary Sjogren's syndrome
SCLC, small cell lung cancer.